GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neuronetics Inc (STU:NRC) » Definitions » Valuation Rank

Neuronetics (STU:NRC) Valuation Rank


View and export this data going back to 2019. Start your Free Trial

What is Neuronetics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Neuronetics Valuation Rank Related Terms

Thank you for viewing the detailed overview of Neuronetics's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuronetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neuronetics Inc (STU:NRC) » Definitions » Valuation Rank
Comparable Companies
VMD PACB SNWV CERS ZIMV TCMD CTKB VREX TLSI OM ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
STIM:USA
Address
3222 Phoenixville Pike, Malvern, PA, USA, 19355
Website
https://www.neurostar.com
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.